{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:00:29Z","timestamp":1780056029727,"version":"3.54.0"},"reference-count":66,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Given that high-risk human papillomavirus (HPV) is the necessary cause of virtually all cervical cancer, the clinical meaning of HPV-negative cervical precancer is unknown. We, therefore, conducted a literature search in Ovid MEDLINE, PubMed Central, and Google Scholar to identify English-language studies in which (i) HPV-negative and -positive, histologically confirmed cervical intraepithelial neoplasia grade 2 or more severe diagnoses (CIN2+) were detected and (ii) summarized statistics or deidentified individual data were available to summarize proportions of biomarkers indicating risk of cancer. Nineteen studies including 3,089 (91.0%) HPV-positive and 307 (9.0%) HPV-negative CIN2+ were analyzed. HPV-positive CIN2+ (vs. HPV-negative CIN2+) was more likely to test positive for biomarkers linked to cancer risk: a study diagnosis of CIN3+ (vs. CIN2; 18 studies; 0.56 vs. 0.24; P &amp;lt; 0.001) preceding high-grade squamous intraepithelial lesion cytology (15 studies; 0.54 vs. 0.10; P &amp;lt; 0.001); and high-grade colposcopic impression (13 studies; 0.30 vs. 0.18; P = 0.03). HPV-negative CIN2+ was more likely to test positive for low-risk HPV genotypes than HPV-positive CIN2+ (P &amp;lt; 0.001). HPV-negative CIN2+ appears to have lower cancer risk than HPV-positive CIN2+. Clinical studies of human high-risk HPV testing for screening to prevent cervical cancer may refer samples of HPV test\u2013negative women for disease ascertainment to correct verification bias in the estimates of clinical performance. However, verification bias adjustment of the clinical performance of HPV testing may overcorrect\/underestimate its clinical performance to detect truly precancerous abnormalities.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-20-0182","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T01:35:14Z","timestamp":1594604114000},"page":"829-840","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus\u2013positive and -Negative Cervical Precancers"],"prefix":"10.1158","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-6554","authenticated-orcid":false,"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[{"name":"1Albert Einstein College of Medicine, Department of Epidemiology and Population Health, Bronx, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-3945","authenticated-orcid":false,"given":"Amanda J.","family":"Pierz","sequence":"additional","affiliation":[{"name":"1Albert Einstein College of Medicine, Department of Epidemiology and Population Health, Bronx, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Adcock","sequence":"additional","affiliation":[{"name":"2Queen Mary University of London, Centre for Cancer Prevention, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shagufta","family":"Aslam","sequence":"additional","affiliation":[{"name":"3Roche Molecular Diagnostics, Pleasanton, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha S.","family":"Basu","sequence":"additional","affiliation":[{"name":"4International Agency for Research on Cancer, Screening Group, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome L.","family":"Belinson","sequence":"additional","affiliation":[{"name":"5Preventive Oncology International and the Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7420-7512","authenticated-orcid":false,"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[{"name":"2Queen Mary University of London, Centre for Cancer Prevention, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"El-Zein","sequence":"additional","affiliation":[{"name":"6Division of Cancer Epidemiology, McGill University, Montr\u00e9al, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catterina","family":"Ferreccio","sequence":"additional","affiliation":[{"name":"7Advanced Center for Chronic Diseases, ACCDiS, Santiago, Chile."},{"name":"8Facultad de Medicina, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Firnhaber","sequence":"additional","affiliation":[{"name":"9School of Medicine, University of Colorado, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-8084","authenticated-orcid":false,"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[{"name":"6Division of Cancer Epidemiology, McGill University, Montr\u00e9al, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti E.","family":"Gravitt","sequence":"additional","affiliation":[{"name":"10Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"Isidean","sequence":"additional","affiliation":[{"name":"6Division of Cancer Epidemiology, McGill University, Montr\u00e9al, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-7881","authenticated-orcid":false,"given":"John","family":"Lin","sequence":"additional","affiliation":[{"name":"11HPV Research Group, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6574-0574","authenticated-orcid":false,"given":"Salaheddin M.","family":"Mahmud","sequence":"additional","affiliation":[{"name":"12Rady Faculty of Health Sciences, Department of Community Health, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Monsonego","sequence":"additional","affiliation":[{"name":"13Institute of the Cervix, Federation Mutualiste Parisienne, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Muwonge","sequence":"additional","affiliation":[{"name":"4International Agency for Research on Cancer, Screening Group, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ratnam","sequence":"additional","affiliation":[{"name":"6Division of Cancer Epidemiology, McGill University, Montr\u00e9al, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Safaeian","sequence":"additional","affiliation":[{"name":"3Roche Molecular Diagnostics, Pleasanton, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"14Division of Cancer Epidemiology & Genetics, NIH, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Smith","sequence":"additional","affiliation":[{"name":"15Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8302-1178","authenticated-orcid":false,"given":"Avril","family":"Swarts","sequence":"additional","affiliation":[{"name":"16Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Wright","sequence":"additional","affiliation":[{"name":"17Department of Pathology and Cell Biology, Columbia University, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Van De Wyngard","sequence":"additional","affiliation":[{"name":"7Advanced Center for Chronic Diseases, ACCDiS, Santiago, Chile."},{"name":"8Facultad de Medicina, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Fu","family":"Xi","sequence":"additional","affiliation":[{"name":"11HPV Research Group, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"2022060815420418600_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","article-title":"Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis","volume":"95","author":"Sherman","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2022060815420418600_bib2","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"2022060815420418600_bib3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"2022060815420418600_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"2022060815420418600_bib5","doi-asserted-by":"crossref","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022060815420418600_bib6","doi-asserted-by":"crossref","first-page":"i4924","DOI":"10.1136\/bmj.i4924","article-title":"Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands","volume":"355","author":"Dijkstra","year":"2016","journal-title":"BMJ"},{"key":"2022060815420418600_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2307\/2530820","article-title":"Assessment of diagnostic tests when disease verification is subject to selection bias","volume":"39","author":"Begg","year":"1983","journal-title":"Biometrics"},{"key":"2022060815420418600_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/096228029800700403","article-title":"Correcting for verification bias in studies of a diagnostic test's accuracy","volume":"7","author":"Zhou","year":"1998","journal-title":"Stat Methods Med Res"},{"key":"2022060815420418600_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bmjebm-2018-110919","article-title":"Verification bias","volume":"23","author":"O'Sullivan","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"2022060815420418600_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0272-2712(18)30065-9","article-title":"Statistical issues in human papillomavirus testing and screening","volume":"20","author":"Franco","year":"2000","journal-title":"Clin Lab Med"},{"key":"2022060815420418600_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"2022060815420418600_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/LGT.0000000000000194","article-title":"Comparison of colposcopic impression based on live colposcopy and evaluation of static digital images","volume":"20","author":"Liu","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"2022060815420418600_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.AOG.0000281665.63550.8f","article-title":"Interobserver agreement in the evaluation of digitized cervical images","volume":"110","author":"Jeronimo","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2022060815420418600_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/gyno.1995.1212","article-title":"Observer agreement on interpreting colposcopic images of CIN","volume":"58","author":"Hopman","year":"1995","journal-title":"Gynecol Oncol"},{"key":"2022060815420418600_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejogrb.2016.08.037","article-title":"Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study","volume":"206","author":"Garutti","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022060815420418600_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/LGT.0000000000000017","article-title":"An online quality assurance program for colposcopy in a population-based cervical screening setting in Italy: results on colposcopic impression","volume":"18","author":"Cristiani","year":"2014","journal-title":"J Low Genit Tract Dis"},{"key":"2022060815420418600_bib17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"2022060815420418600_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000381","article-title":"The interpretive variability of cervical biopsies and its relationship to HPV status","volume":"39","author":"Stoler","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"2022060815420418600_bib19","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/PAS.0b013e318058a544","article-title":"Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists","volume":"31","author":"Cai","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2022060815420418600_bib20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","article-title":"p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia","volume":"26","author":"Klaes","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"2022060815420418600_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/PAS.0000000000001072","article-title":"Routine use of adjunctive p16 immunohistochemistry improves diagnostic agreement of cervical biopsy interpretation: results from the CERTAIN study","volume":"42","author":"Stoler","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"2022060815420418600_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"2022060815420418600_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"2022060815420418600_bib24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"2022060815420418600_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/sj.bjc.6690730","article-title":"HPV testing in primary screening of older women","volume":"81","author":"Cuzick","year":"1999","journal-title":"Br J Cancer"},{"key":"2022060815420418600_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1159\/000328554","article-title":"ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants","volume":"44","author":"Schiffman","year":"2000","journal-title":"Acta Cytol"},{"key":"2022060815420418600_bib27","first-page":"945","article-title":"Human papillomavirus testing for primary screening of cervical cancer precursors","volume":"9","author":"Ratnam","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060815420418600_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G","article-title":"Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy","volume":"89","author":"Schneider","year":"2000","journal-title":"Int J Cancer"},{"key":"2022060815420418600_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/gyno.2001.6370","article-title":"Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia","volume":"83","author":"Belinson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"2022060815420418600_bib30","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","article-title":"Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral","volume":"288","author":"Kulasingam","year":"2002","journal-title":"JAMA"},{"key":"2022060815420418600_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/ijgc-00009577-200311000-00013","article-title":"Shanxi Province Cervical Cancer Screening Study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology","volume":"13","author":"Belinson","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"2022060815420418600_bib32","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART Study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"2022060815420418600_bib33","doi-asserted-by":"crossref","first-page":"e13711","DOI":"10.1371\/journal.pone.0013711","article-title":"Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India","volume":"5","author":"Gravitt","year":"2010","journal-title":"PLoS One"},{"key":"2022060815420418600_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1309\/AJCPKA6ATAPBZ6JQ","article-title":"A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study","volume":"135","author":"Belinson","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"2022060815420418600_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"key":"2022060815420418600_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2011.10.031","article-title":"Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo","volume":"124","author":"Mahmud","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2022060815420418600_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2022060815420418600_bib38","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.27662","article-title":"Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile","volume":"132","author":"Ferreccio","year":"2013","journal-title":"Int J Cancer"},{"key":"2022060815420418600_bib39","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1940-6207.CAPR-13-0091","article-title":"An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China","volume":"6","author":"Zhao","year":"2013","journal-title":"Cancer Prev Res"},{"key":"2022060815420418600_bib40","doi-asserted-by":"crossref","first-page":"e53494","DOI":"10.1371\/journal.pone.0053494","article-title":"Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa","volume":"8","author":"Firnhaber","year":"2013","journal-title":"PLoS One"},{"key":"2022060815420418600_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.29458","article-title":"Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India","volume":"137","author":"Basu","year":"2015","journal-title":"Int J Cancer"},{"key":"2022060815420418600_bib42","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/ijc.30385","article-title":"Human papillomavirus testing versus cytology in primary cervical cancer screening: end-of-study and extended follow-up results from the Canadian Cervical Cancer Screening Trial","volume":"139","author":"Isidean","year":"2016","journal-title":"Int J Cancer"},{"key":"2022060815420418600_bib43","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The Onclarity Human Papillomavirus Trial: design, methods, and baseline results","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol Oncol"},{"key":"2022060815420418600_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"2022060815420418600_bib45","volume-title":"High grade squamous intraepithelial lesion (HSIL)","author":"Khieu","year":"2020"},{"key":"2022060815420418600_bib46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/AOG.0b013e318168460b","article-title":"An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS)","volume":"111","author":"Castle","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2022060815420418600_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00128360-200410000-00005","article-title":"False-negative hybrid capture II results related to altered adhesion molecule distribution in women with atypical squamous cells pap smear results and tissue-based human papillomavirus-positive high-grade cervical intraepithelial neoplasia","volume":"8","author":"Lonky","year":"2004","journal-title":"J Low Genit Tract Dis"},{"key":"2022060815420418600_bib48","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/509511","article-title":"Human papillomavirus prevalence in women who have and have not undergone hysterectomies","volume":"194","author":"Castle","year":"2006","journal-title":"J Infect Dis"},{"key":"2022060815420418600_bib49","first-page":"1550","article-title":"Cervical cancer screening among women without a cervix","volume":"292","author":"Castle","year":"2004","journal-title":"JAMA"},{"key":"2022060815420418600_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"2022060815420418600_bib51","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"2022060815420418600_bib52","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"2022060815420418600_bib53","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/1471-0528.13839","article-title":"Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium","volume":"123","author":"Sasieni","year":"2016","journal-title":"BJOG"},{"key":"2022060815420418600_bib54","volume-title":"Human papillomaviruses.","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2007"},{"key":"2022060815420418600_bib55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"2022060815420418600_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol"},{"key":"2022060815420418600_bib57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000001301","article-title":"Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV\/AIDS: effect of anti-retroviral therapy","volume":"31","author":"Kelly","year":"2017","journal-title":"AIDS"},{"key":"2022060815420418600_bib58","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"2022060815420418600_bib59","doi-asserted-by":"crossref","first-page":"ky063","DOI":"10.1093\/jncics\/pky063","article-title":"Epidemiology, biology, treatment, and prevention of ductal carcinoma in situ (DCIS)","volume":"2","author":"Punglia","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"2022060815420418600_bib60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-2007-1004268","article-title":"Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics","volume":"29","author":"Nusko","year":"1997","journal-title":"Endoscopy"},{"key":"2022060815420418600_bib61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa1100370","article-title":"Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths","volume":"366","author":"Zauber","year":"2012","journal-title":"N Engl J Med"},{"key":"2022060815420418600_bib62","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJM199312303292701","article-title":"Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup","volume":"329","author":"Winawer","year":"1993","journal-title":"N Engl J Med"},{"key":"2022060815420418600_bib63","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"key":"2022060815420418600_bib64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"2022060815420418600_bib65","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5858\/arpa.2019-0241-OA","article-title":"Relationships of p16 immunohistochemistry and other biomarkers with diagnoses of cervical abnormalities: implications for LAST terminology","volume":"144","author":"Castle","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"2022060815420418600_bib66","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1002\/ijc.30032","article-title":"Evaluating HPV-negative CIN2+ in the ATHENA trial","volume":"138","author":"Petry","year":"2016","journal-title":"Int J Cancer"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/13\/10\/829\/1935821\/829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/13\/10\/829\/1935821\/829.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:09:52Z","timestamp":1654690192000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/13\/10\/829\/47323\/A-Pooled-Analysis-to-Compare-the-Clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,2]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-20-0182","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22534523","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547535","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22534523.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22534526","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22534526.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547535.v1","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}